A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
Phase of Trial: Phase I/II
Latest Information Update: 12 Aug 2015
At a glance
- Drugs Chlorambucil (Primary) ; Ofatumumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 22 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jul 2014 Planned End Date changed from 1 Aug 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov.